Share on StockTwits

Pressure BioSciences (NASDAQ:PBIO) CEO Richard T. Schumacher bought 13,200 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, August 26th. The stock was purchased at an average cost of $0.30 per share, for a total transaction of $3,960.00. Following the purchase, the chief executive officer now directly owns 669,504 shares of the company’s stock, valued at approximately $200,851. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

Pressure BioSciences (NASDAQ:PBIO) traded down 3.33% on Thursday, hitting $0.29. The stock had a trading volume of 4,566 shares. Pressure BioSciences has a 52 week low of $0.16 and a 52 week high of $0.78. The stock has a 50-day moving average of $0.33 and a 200-day moving average of $0.43. The company’s market cap is $4.5 million.

Pressure BioSciences (NASDAQ:PBIO) last announced its earnings results on Thursday, August 14th. The company reported ($0.05) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.11) by $0.06. On average, analysts predict that Pressure BioSciences will post $-0.43 earnings per share for the current fiscal year.

Pressure BioSciences, Inc is focused on solving the challenging problems inherent in biological sample preparation, a crucial laboratory step performed by scientists worldwide working in biological life sciences research.

Receive News & Ratings for Pressure BioSciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure BioSciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.